An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.
Prohibits non-compete agreements for employees earning under $75,000, boosting mobility and competition, with enforcement by the AG and civil remedies.